GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gennbio Inc (XKRX:072520) » Definitions » EV-to-EBITDA

Gennbio (XKRX:072520) EV-to-EBITDA : -12.64 (As of Sep. 22, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Gennbio EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Gennbio's enterprise value is ₩51,650 Mil. Gennbio's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-4,086 Mil. Therefore, Gennbio's EV-to-EBITDA for today is -12.64.

The historical rank and industry rank for Gennbio's EV-to-EBITDA or its related term are showing as below:

XKRX:072520' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1070.65   Med: -4.37   Max: 15534.37
Current: -12.64

During the past 13 years, the highest EV-to-EBITDA of Gennbio was 15534.37. The lowest was -1070.65. And the median was -4.37.

XKRX:072520's EV-to-EBITDA is not ranked
in the Biotechnology industry.
Industry Median: 8.73 vs XKRX:072520: -12.64

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-09-22), Gennbio's stock price is ₩389.00. Gennbio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-272.000. Therefore, Gennbio's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Gennbio EV-to-EBITDA Historical Data

The historical data trend for Gennbio's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gennbio EV-to-EBITDA Chart

Gennbio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.28 -22.83 -7.19 -6.65 -20.13

Gennbio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.64 -6.28 -5.83 -20.13 -11.66

Competitive Comparison of Gennbio's EV-to-EBITDA

For the Biotechnology subindustry, Gennbio's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gennbio's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gennbio's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Gennbio's EV-to-EBITDA falls into.



Gennbio EV-to-EBITDA Calculation

Gennbio's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=51649.611/-4086.195
=-12.64

Gennbio's current Enterprise Value is ₩51,650 Mil.
Gennbio's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-4,086 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gennbio  (XKRX:072520) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Gennbio's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=389.00/-272.000
=At Loss

Gennbio's share price for today is ₩389.00.
Gennbio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-272.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Gennbio EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Gennbio's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Gennbio Business Description

Traded in Other Exchanges
N/A
Address
5th Floor, Teheran Road, Gangnam-gu, 422 KT Seolleung Tower, Seoul, KOR
Gennbio Inc builds drug and bio long-term development platform. The company produces models of primate diseases such as organ transplants and immune or diabetic models.

Gennbio Headlines

No Headlines